How do brain-penetrant SPI1 modulators affect essential myeloid cell functions versus pathological inflammation?

drug-development open
Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
—
Novelty
—
Mechanistic
—
Druggability
—
Priority
71%
Importance
—
Tractability
—
Market price
50%

Description

The debate raised critical safety concerns about disrupting SPI1’s homeostatic roles while targeting neuroinflammation. The therapeutic window and selectivity requirements remain undefined, limiting clinical translation.

Source: Debate session sess_SDA-2026-04-08-gap-pubmed-20260406-062122-bfac06c8 (Analysis: SDA-2026-04-08-gap-pubmed-20260406-062122-bfac06c8)